(Reuters) – Moderna Inc’s shares fell nearly 10% after losing a bid to invalidate a US patent owned by Arbutus Biopharma that represents a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine. . FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »
AstraZeneca Plc fell from a record in New York trade after data for the company’s Covid-19 vaccine candidate, while promising, fueled concerns about whether it can match competitors. Bernstein analysts led by Ronny Gal said the vaccine, developed in association with the University of Oxford, showed initial positive data, but …
Read More »
Modern Pharmaceutical (MRNA) – Get report, one of the leading candidates to produce a viable coronavirus vaccine, fell on Monday after Oxford University and AstraZeneca (AZN) – Get report published promising data from an early-stage trial of a key coronavirus vaccine study, and the population received a downgrade from JP …
Read More »
As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »